Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Electromed, Inc. ELMD

Healthcare  —  Medical Devices
27.88 0.02 0.07% as of 25 Sep
Market cap
$233.1M
P/E
20.4×
Revenue Champion (10y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Electromed, Inc. (ELMD) Business Profile

Updated before January 2025

Company Overview

Electromed, Inc. (ELMD) is a leading medical device company specializing in innovative airway clearance technologies. Founded in 1992 and headquartered in New Prague, Minnesota, the company has established itself as a pioneer in providing solutions for patients with chronic respiratory conditions. Electromed’s flagship product, the SmartVest® Airway Clearance System, has become a cornerstone in the treatment of conditions such as cystic fibrosis, bronchiectasis, and other pulmonary disorders. The company is led by a team of experienced executives, including Kathleen Skarvan, who serves as the President and Chief Executive Officer. Under her leadership, Electromed has focused on expanding its market presence, enhancing product innovation, and driving sustainable growth.

Core Business Segments

Electromed operates primarily in the medical device industry, with a focus on airway clearance therapy. The company’s core business segments include:

Airway Clearance Systems

  • SmartVest® Airway Clearance System: This is Electromed’s flagship product, designed to help patients clear mucus from their lungs effectively. The system uses High-Frequency Chest Wall Oscillation (HFCWO) technology to improve lung function and reduce the risk of respiratory infections.
  • SmartVest Connect®: A digital platform that integrates with the SmartVest system, allowing patients and healthcare providers to monitor therapy adherence and outcomes in real-time.

Patient Support Services

  • Reimbursement Assistance: Electromed provides comprehensive support to patients in navigating insurance coverage and reimbursement for its products.
  • Clinical Support: The company offers personalized training and education to ensure patients and caregivers can use the SmartVest system effectively.

Research and Development

Electromed invests significantly in R&D to enhance its existing product portfolio and develop new technologies. The company is committed to advancing airway clearance therapy through continuous innovation.

Business Model

Electromed’s business model revolves around the integration of cutting-edge medical devices with robust patient support services. The company generates revenue primarily through the sale of its SmartVest systems and related accessories. Additionally, Electromed offers ongoing support to patients, which helps build long-term relationships and ensures consistent revenue streams. The company’s direct-to-patient sales approach, combined with its focus on reimbursement assistance, has enabled it to maintain a strong presence in the U.S. market.

Strategic Direction

Electromed is focused on several strategic initiatives to drive future growth:

  • Market Expansion: The company aims to expand its presence in international markets while continuing to grow its footprint in the U.S.
  • Product Innovation: Electromed is committed to enhancing its SmartVest technology and exploring new product categories to address unmet medical needs.
  • Sustainability Goals: The company is working towards reducing its environmental impact by adopting sustainable manufacturing practices and materials.
  • Digital Integration: With the launch of SmartVest Connect®, Electromed is leveraging digital health technologies to improve patient outcomes and engagement.

Competitive Landscape

Electromed operates in a competitive market, facing challenges from both established players and emerging companies. Key competitors include:

  • Hill-Rom Holdings, Inc.: A major player in the respiratory care market, offering a range of airway clearance devices.
  • Philips Respironics: Known for its innovative respiratory care solutions, including airway clearance systems.
  • RespirTech (a Philips company): A direct competitor in the HFCWO market, offering similar products to Electromed’s SmartVest.

Despite the competition, Electromed differentiates itself through its focus on patient-centric solutions, superior customer support, and continuous innovation.

Risk Factors

Electromed faces several risks that could impact its business operations and financial performance:

  • Market Dependence: The company relies heavily on the success of its SmartVest system, making it vulnerable to market fluctuations and competitive pressures.
  • Regulatory Challenges: As a medical device manufacturer, Electromed must comply with stringent regulatory requirements, which can be time-consuming and costly.
  • Supply Chain Disruptions: Global supply chain issues, including shortages of critical components, could affect the company’s ability to meet demand.
  • Reimbursement Risks: Changes in healthcare policies and insurance reimbursement rates could impact the affordability and accessibility of Electromed’s products.

Recent Developments

Electromed has made significant strides in recent years, including:

  • Launch of SmartVest Connect®: This digital platform has enhanced the functionality of the SmartVest system, providing patients and healthcare providers with valuable insights into therapy adherence.
  • Expansion of Sales Team: The company has increased its sales force to drive growth in key markets.
  • COVID-19 Impact: While the pandemic posed challenges, it also highlighted the importance of respiratory care, leading to increased awareness and demand for Electromed’s products.

Investment Considerations

Strengths

  • Innovative Product Portfolio: Electromed’s SmartVest system is a market leader in airway clearance therapy.
  • Strong Customer Support: The company’s focus on patient education and reimbursement assistance sets it apart from competitors.
  • Growth Potential: With plans for market expansion and product innovation, Electromed is well-positioned for future growth.

Risks

  • Market Concentration: Dependence on a single product line could pose challenges if market conditions change.
  • Regulatory and Reimbursement Risks: Compliance with healthcare regulations and changes in insurance policies could impact the company’s operations.

Conclusion

Electromed, Inc. is a leader in the airway clearance therapy market, driven by its innovative SmartVest system and commitment to patient care. While the company faces challenges such as market dependence and regulatory risks, its focus on product innovation, market expansion, and sustainability positions it for long-term growth. For investors, Electromed offers a compelling opportunity, backed by a strong product portfolio and a clear strategic vision for the future.